Elixir is a centralized platform aggregating data from various sources, such as USPTO, EPO, and the Orange Book. It uses advanced monitoring tools and algorithms to track drug patents, regulatory updates, and market activities. Users can customize their preferences and receive regular email summaries of their desired information.